Skip to search.
 Dow Down 0.60% Nasdaq Down 0.07%

ResMed Inc. (RMD)

-NYSE

31.58 Down 0.51(1.59%) May 25, 4:05PM EDT|After Hours: 31.58 0.00 (0.00%) May 25, 4:28PM EDT

ProfileGet Profile for:
ResMed Inc.
9001 Spectrum Center Boulevard
San Diego, CA 92123
United States - Map
Phone: 858-836-5000
Fax: 858-836-5501
Website: http://www.resmed.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Appliances & Equipment
Full Time Employees:3,450

Business Summary 

ResMed Inc., through its subsidiaries, engages in the development, manufacture, and distribution of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. It offers various products for the treatment of obstructive sleep apnea and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear, ventilation devices, and other accessories, such as cold passover humidifiers, carry bags, and breathing circuits. The company also offers data communications and data control products, such as ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. ResMed Inc. markets its products to sleep clinics, home healthcare dealers, and third party payers. The company sells its products through a network of distributors, independent manufacturers, representatives, and direct sales force in approximately 70 countries primarily in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Norway, and Sweden. ResMed Inc. was founded in 1989 and is based in San Diego, California.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on ResMed Inc.

Corporate Governance 
ResMed Inc.’s Governance Risk Indicator (GRI®) as of May 1, 2012 is: Audit (Low Concern), Board (Low Concern), Compensation (Low Concern), Shareholder Rights (Low Concern).
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Dr. Peter C. Farrell Ph.D., ScD, AM, 69
Founder, Exec. Chairman, Chief Exec. Officer and Pres
1.44M6.05M
Mr. Brett A. Sandercock , 44
Chief Financial Officer and Principal Accounting Officer
842.00K852.00K
Mr. Robert Douglas , 52
Chief Operating Officer
767.00K737.00K
Mr. David Pendarvis , 53
Chief Admin. officer, Global Gen. Counsel and Sec.
775.00K1.53M
Mr. Jim Hollingshead ,
Chief Strategy Officer
N/AN/A
Amounts are as of Dec 31, 2011 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders